PERSPECTA

News from every angle

← Back to headlines

TransMedics Targets 20-25% Revenue Growth by 2026

TransMedics has outlined an ambitious target of 20-25% revenue growth by 2026, driven by advancements in its OCS programs and strategic expansion into European markets.

25 Feb, 07:08 — 25 Feb, 07:08
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha2d ago

TransMedics outlines 20–25% 2026 revenue growth target while advancing OCS programs and European expansion

Read full article →

Related Stories

Philippine LTFRB Suspends Three TNCs Over Franchise Violations

just now

Asian markets rally as traders reassess AI investment value

just now

Cynosure Lutronic Gains Regulatory Approvals in China and Japan for Clarity II™

5m ago

Deutsche Bahn Reaches Tariff Agreement, CFO Departs

7m ago